Overview
Retail Trade

Pharmarise Holdings Corporation

Pharmarise Holdings Co., Ltd. is a holding company operating primarily through its dispensing pharmacy business, which fills prescriptions issued by medical institutions across Japan through multiple subsidiaries including Pharmarise Co., Ltd., Chemist Co., Ltd., Healthy Work Co., Ltd., and others. In addition to its core dispensing pharmacy operations, the Group conducts ancillary businesses including retail sales (cosmetics, convenience stores, drugstores), medical record storage and management, medical mall operations at JR Sapporo Station, IT solutions for pharmaceutical companies and healthcare providers, staffing and job placement services, and day-care/visiting nursing/senior housing services.

Market Cap
¥5.82B
US$37.1M
EV
¥16.9B
US$108M
Stock¥506▼-0.39%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
6.8
x
LTM EV/EBIT
18.9
x
LTM PER
60.6
x
LTM PBR
0.9
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-27.1%pt
100
Oct 24, 25 – Oct 23, 26StockTOPIX
MC → EV Bridge
5.82BUS$37.1MMarket Cap14.4BUS$91.8M+ Debt2.94BUS$18.8M− Cash0.34BUS$2.16M− Inv. Sec.0.02BUS$0.11M+ NCI16.9BUS$108MEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
51.6US$329M'22/552.0US$332M'23/554.5US$347M'24/563.5US$405M'25/569.5US$443M'26/5
EBITDA 5Y (¥B)
2.13US$13.6M'22/52.03US$12.9M'23/51.53US$9.75M'24/51.02US$6.52M'25/51.76US$11.2M'26/5
Net Income 5Y (¥B)
0.45US$2.85M'22/50.33US$2.12M'23/5-0.35-US$2.24M'24/5-0.37-US$2.34M'25/50.11US$0.73M'26/5
Capital Structure
31%
69%
EquityD/E 2.24xDebt
Liquidity vs Debt 5Y (¥B)▼ Net Debt
CashInv. Sec.Debt
4.05US$25.8M9.91US$63.2M'22/54.82US$30.8M7.66US$48.8M'23/57.22US$46.0M12.7US$81.3M'24/55.25US$33.5M14.3US$91.1M'25/56.35US$40.5M15.2US$96.6M'26/5
Shareholders
Top 10 hold 67.7%
1
Big Field Co., Ltd.
26.20%
2
SUZUKEN CO.,LTD.
20.10%
3
Sayoko OHNO
4.50%
4
Tomichi OHNO
3.70%
5
Pharmarise Holdings Corporation Employee Stock Ownership Association
3.60%
6
Nakakita Yakuhin Co., Ltd.
3.40%
7
Vital Net Co., Ltd.
3.40%
8
Jin HIRAMATSU
1.00%
9
FamilyMart Co.,Ltd.
0.90%
10
Meiji Yasuda Life Insurance Company
0.90%
Management
12 officers
Tomichi OHNO
Chairman of the Board, Director
Nov 1971 Joined Marutake Co., Ltd. Jun 1984 Assumed office as Representative Director, President concurrent with founding of the Company Jan 1997 Assumed office as Representative Director, President of Minami Yakkyoku Co., Ltd. May 2002 Director of Minami Yakkyoku Co., Ltd. Sep 2007 Assumed office as Representative Director, President of Fujii Yakkyoku Co., Ltd. Jun 2009 Changed name of Pharmalize Co., Ltd. to Pharmalize Holdings Co., Ltd.; established Pharmalize Co., Ltd. through new incorporation-type company split; assumed office as Representative Director, President concurrently Mar 2013 Assumed office as Representative Director, President of Pharmalize Plus Co., Ltd. Aug 2015 Assumed office as Representative Director, Executive Officer, President of the Company Oct 2015 Assumed office as Representative Director, President of Kusuri Higuchi & Pharmalize Co., Ltd. Aug 2016 Assumed office as Representative Director, Chairman of the Company Jun 2017 Director of Mutus Co., Ltd. Jan 2019 Assumed office as Chairman of the Board of Pharmalize Co., Ltd. Mar 2020 Director of Healthy Work Co., Ltd. Dec 2022 Director of Hokkaido Pharmalize Co., Ltd. Jan 2024 Director of GOOD AID Co., Ltd. Aug 2024 Assumed office as Chairman of the Board, Director of the Company (current)
1950-04-16
Sayoko OHNO
Vice Chairman, Director
Apr 1973 Joined Marutake Co., Ltd. Jul 1989 Assumed office as Director of the Company Jul 2001 Assumed office as Managing Director of the Company Sep 2007 Assumed office as General Manager, Administration Division of the Company Jun 2009 Changed name of Pharmalize Co., Ltd. to Pharmalize Holdings Co., Ltd.; established Pharmalize Co., Ltd. through new incorporation-type company split; assumed office as Director concurrently Aug 2009 Assumed office as Director of Minami Yakkyoku Co., Ltd. Aug 2015 Assumed office as Director of Futaba Co., Ltd. Aug 2016 Assumed office as Advisor of the Company Aug 2018 Assumed office as Managing Director and Executive Officer of the Company Aug 2019 Assumed office as Director of Ray Care Center Co., Ltd. (current) Aug 2020 Assumed office as Vice Chairman, Director of the Company (current)
1949-06-03
Masayuki AKIYAMA
Representative Director, President
Apr 1995 Joined Kyowa Shizuoka Co., Ltd. Jul 1995 Assumed office as Representative Director, President of Kyowa Shizuoka Co., Ltd. Feb 1997 Assumed office as Director of the Company through merger Mar 2005 Assumed office as President of Japan Pharmacokinetics Research Institute Jul 2006 Assumed office as Director of Pharmalize Institute of Medical Information Jun 2009 Changed name of Pharmalize Co., Ltd. to Pharmalize Holdings Co., Ltd.; established Pharmalize Co., Ltd. through new incorporation-type company split; assumed office as Senior Managing Director concurrently Sep 2009 Assumed office as Representative Director, President of Pharmalize Co., Ltd. Aug 2010 Assumed office as Senior Managing Director of the Company Mar 2014 Assumed office as Representative Director, President of Kinugawa Pharmacy Center Co., Ltd. Aug 2016 Assumed office as Representative Director, President of Pharmalize Plus Co., Ltd. Aug 2018 Assumed office as Representative Director, President of the Company (current) Oct 2018 Director of Chemist Co., Ltd. (current) Jan 2019 Director of Pharmalize Co., Ltd. (current) Mar 2020 Director of Kotobuki Data Bank Co., Ltd. (current) Mar 2020 Director of Healthy Work Co., Ltd. (current) Aug 2021 Director of Mutus Co., Ltd. (current) Jan 2024 Assumed office as Representative Director, President of GOOD AID Co., Ltd. (current)
1967-02-16
Keiko MATSUURA
Senior Managing Director
Sep 1979 Joined Ansei-kai Mizusawa Hospital (medical corporation) May 1983 Joined Shojun-kai Sakakibara Onsen Hospital (medical corporation) Apr 2000 Joined the Company Aug 2009 Assumed office as Director of Minami Yakkyoku Co., Ltd. Sep 2009 Assumed office as Director and Business Division Manager of Minami Yakkyoku Co., Ltd. Oct 2010 Assumed office as Director of Hay Corporation Oct 2012 Assumed office as Representative Director, President of Minami Yakkyoku Co., Ltd. and Kitamachi Pharmacy Co., Ltd. Nov 2012 Assumed office as Executive Officer of the Company Jun 2013 Assumed office as Director of Tokyo Minami Yakkyoku Co., Ltd. Oct 2016 Assumed office as General Manager, Pharmacy Division, Business Promotion Headquarters of the Company; Director of Tokai Pharmalize Co., Ltd. Aug 2017 Assumed office as Director of For You Co., Ltd. Aug 2018 Assumed office as Senior Managing Director of the Company (current); Representative Director, President of Kansai Pharmalize Co., Ltd. Jan 2019 Assumed office as Representative Director, President of Pharmalize Co., Ltd. (current) Aug 2021 Director of Healthy Work Co., Ltd. (current) Dec 2022 Director of Hokkaido Pharmalize Co., Ltd. (current) Dec 2024 Assumed office as Representative Director, President of next PH Co., Ltd. (current)
1956-12-20
Yutaka NUMATA
Director
Apr 1987 Joined Yamaichi Securities Co., Ltd. Feb 1998 Joined Fuji Securities Co., Ltd. Feb 2012 Joined the Company Mar 2014 Assumed office as Director of Kinugawa Pharmacy Center Co., Ltd. Aug 2015 Assumed office as General Manager, Corporate Planning Department of the Company Oct 2015 Assumed office as Director of Kusuri Higuchi & Pharmalize Co., Ltd. Aug 2016 Assumed office as Executive Officer and General Manager, Management Strategy Headquarters of the Company Mar 2017 Assumed office as Director of MC Co., Ltd. Jun 2017 Assumed office as Director of Mutus Co., Ltd. Jun 2018 Assumed office as Director of Medical Front Co., Ltd. (current) Jun 2018 Assumed office as Director of Pocket Pharmacy Sales Co., Ltd. Aug 2018 Assumed office as Director of the Company (current) May 2020 Assumed office as Director of Week Co., Ltd. (current) Aug 2026 Assumed office as Representative Director, President of Mutus Co., Ltd. (current)
1963-07-26
Hiroshi SUGANO
Director
Apr 1995 Joined Angel Pharmacy Co., Ltd. Jan 2001 Transferred to the Company through merger with Angel Pharmacy Co., Ltd. Jun 2004 Assumed office as Pharmacy Operations Section Manager, Pharmacy Division of the Company Sep 2007 Assumed office as General Manager, Related Business Division of the Company Apr 2010 Assumed office as General Manager, Group Operations Management Department of the Company; General Manager, Headquarters Oct 2010 Assumed office as Director, General Manager, Headquarters and General Manager, Affiliated Companies Division of the Company Aug 2011 Assumed office as Representative Director of Pharmalize Co., Ltd. Oct 2011 Assumed office as Executive Officer of the Company Aug 2012 Assumed office as Director and Executive Officer of the Company Jun 2014 Assumed office as Director, Executive Officer and General Manager, Regional Medical Promotion Office of the Company Sep 2016 Assumed office as Executive Officer, Deputy General Manager, Business Promotion Headquarters and General Manager, Regional Medical Promotion Office of the Company Oct 2018 Assumed office as General Manager, Corporate Planning Department of the Company Mar 2019 Assumed office as General Manager, Human Resources Department of the Company Aug 2020 Assumed office as Director of the Company (current) Mar 2024 Assumed office as Director of At Aroma Co., Ltd. (current) Nov 2024 Assumed office as General Manager, DX Promotion Department of the Company (current)
1973-02-06
Hiroshi TADA
Director
Apr 1960 Assumed office as Commercial Subject Teacher, Jitsugaku Commercial High School, Jitsugaku Gakuen Apr 1973 Joined Canyon Co., Ltd.; assumed office as Director and General Manager, Administration Division Apr 1974 Assumed office as Senior Managing Director of Canyon Co., Ltd. Apr 1975 Assumed office as Director, USA, Canyon Manufacturing Company Apr 1976 Assumed office as Representative Director, President of Korea Canyon Co., Ltd. Apr 1978 Assumed office as Representative Director, President of Canyon Tsusho Co., Ltd. (now Tasman Co., Ltd.) (current) Aug 2016 Assumed office as Director of the Company (current)
1936-09-01
Ai AIZAWA
Director
Apr 1996 Registered as Attorney-at-Law (Daini Tokyo Bar Association); joined Hamada Law Office Sep 2005 Assumed office as Chairperson of NPO Mirai Kodomo Land Dec 2007 Opened Aizawa Law Office; assumed office as Head Attorney (current) Jun 2011 Assumed office as Member of Nerima City Administrative Evaluation Committee Apr 2012 Assumed office as Member of Fair Committee, Nishitokyo City, Yusenen Union and Tama Rokuto Science Center Union May 2012 Assumed office as Special Investigator for Reemployment, Cabinet Office (part-time) Apr 2013 Assumed office as Member of Community-Based Service Operations Committee, Nishitokyo City Apr 2014 Assumed office as Ombudsman, Chofu City Apr 2015 Assumed office as Member of Nerima City Administrative Reform Promotion Council Jun 2019 Assumed office as Director of Oizumi Kikumi-kai (social welfare corporation) (current) May 2020 Assumed office as Councilor of Housing Finance Promotion Association (general incorporated foundation) (current) Oct 2022 Assumed office as Member of Kokubunji City Political Ethics Review Committee (current) Jan 2024 Assumed office as Director of the Company (current) Jul 2025 Assumed office as Partner Certified Tax Accountant, Kitajima Sogo Accounting Firm (current)
1967-04-15
Tsuneo SONOBE
Director
Mar 1995 Joined Takazono Co., Ltd. Mar 1996 Assumed office as Director of Takazono Co., Ltd. Dec 1999 Assumed office as Senior Managing Director of Takazono Co., Ltd. Nov 2003 Assumed office as Representative Director, President of Takazono Co., Ltd. Jun 2010 Assumed office as Representative Director, President of Takazono Technology Co., Ltd. Jul 2012 Assumed office as Chairman of TAKAZONO VIETNAM Feb 2015 Assumed office as Director of Takazono Technology Co., Ltd. (current) Apr 2015 Assumed office as Representative Director, Chairman of Takazono Co., Ltd. (current) May 2017 Assumed office as Director of Japan Medical Device Association (current) Aug 2020 Assumed office as Corporate Auditor of the Company Aug 2024 Assumed office as Director of the Company (current)
1963-04-10
Makoto MIURA
Full-time Corporate Auditor
Apr 1972 Joined The Mitsubishi Bank, Ltd. Mar 2006 Seconded to the Company as Deputy General Manager, General Affairs Department Aug 2006 Transferred to the Company Nov 2006 Assumed office as Deputy General Manager, Management Department and Section Manager, Planning Section of the Company Mar 2007 Assumed office as General Manager, General Affairs Department of the Company Apr 2008 Assumed office as General Manager, Headquarters of the Company Aug 2008 Assumed office as Director and General Manager, Headquarters of the Company Sep 2009 Assumed office as Director of Pharmalize Co., Ltd.; General Manager, Store Operations Department Apr 2011 Assumed office as Representative Director, President of Hokkaido Pharmalize Co., Ltd. Oct 2011 Assumed office as Executive Officer of the Company Jun 2013 Assumed office as General Manager, Affiliated Companies Division of the Company Jun 2014 Assumed office as Director and General Manager, Business Division of Pharmalize Co., Ltd. Jan 2018 Assumed office as Director and General Manager, Business Management Department of Pharmalize Co., Ltd. Mar 2020 Assumed office as Section Manager, General Affairs Section, Administration Division of the Company Dec 2023 Assumed office as Corporate Auditor of Pharmalize Co., Ltd. (current) Dec 2023 Assumed office as Corporate Auditor of Hokkaido Pharmalize Co., Ltd. (current) Jan 2024 Assumed office as Full-time Corporate Auditor of the Company (current) Jan 2024 Assumed office as Corporate Auditor of GOOD AID Co., Ltd. (current) Dec 2024 Assumed office as Corporate Auditor of next PH Co., Ltd. (current)
1953-08-08
Takayuki ENOMOTO
Part-time Corporate Auditor
Oct 1987 Joined Chuo Audit Corporation Mar 1991 Registered as Certified Public Accountant Jan 1993 Opened Enomoto CPA Office; assumed office as Head Certified Public Accountant (current) Sep 1995 Registered as Licensed Tax Accountant Aug 2017 Elected as Substitute Corporate Auditor of the Company Sep 2017 Assumed office as Corporate Auditor of the Company (current) Jul 2022 Assumed office as Standing Director, Tokyo Chapter, Japanese Institute of Certified Public Accountants (current) Jul 2025 Assumed office as Standing Auditor, Tokyo Tax Accountants Association (current)
1962-06-05
Takao SUZUKI
Part-time Corporate Auditor
Oct 1975 Joined Fuso Audit Corporation Feb 1977 Joined Minoru Watanabe CPA Office Apr 1980 Joined Eiko Audit Corporation Aug 1981 Registered as Certified Public Accountant Jan 1985 Posted to New York Office of Century Audit Corporation (formerly Eiko Audit Corporation) (until Jul 1988) Dec 1988 Joined Kawashima CPA Joint Office May 1989 Registered as Licensed Tax Accountant Mar 2002 Opened Takao Suzuki CPA and Tax Accountant Office Jan 2021 Assumed office as Partner, Chuwa LLC Audit Corporation (current) Aug 2024 Assumed office as Corporate Auditor of the Company (current)
1949-07-25
Large Shareholding Reports
Big Field Co., Ltd.
2025-10-07
25.00%→25.00%
Annual report (as of 2026-05-31): 26.20%
Disclosures
No disclosures
Primary Source Filings
TDnet
2026-09-17
Q1 Earnings Flash
EDINET
2026-08-20
Annual Securities Report
Period: Jun 2025 – May 2026
TDnet
2026-06-25
Full-Year Earnings Flash
TDnet
2026-03-19
Q3 Earnings Flash
EDINET
2026-01-09
Semi-Annual Securities Report
Period: Jun 2025 – May 2026
EDINET
2025-10-07
Large Shareholding Report
TDnet
2025-09-25
Q1 Earnings Flash
EDINET
2025-08-25
Annual Securities Report
Period: Jun 2024 – May 2025
TDnet
2025-03-25
Q3 Earnings Flash
EDINET
2025-01-10
Semi-Annual Securities Report
Period: Jun 2024 – May 2025
TDnet
2024-09-25
Q1 Earnings Flash
EDINET
2024-08-30
Annual Securities Report
Period: Jun 2023 – May 2024
EDINET
2024-04-10
Quarterly Securities Report
Period: Dec 2023 – Feb 2024
EDINET
2024-01-10
Quarterly Securities Report
Period: Sep 2023 – Nov 2023
EDINET
2023-10-11
Quarterly Securities Report
Period: Jun 2023 – Aug 2023
EDINETAmended
2023-09-13
Amended Securities Registration Statement
EDINET
2023-09-12
Securities Registration Statement
EDINET
2023-08-31
Annual Securities Report
Period: Jun 2022 – May 2023
EDINET
2023-04-07
Quarterly Securities Report
Period: Dec 2022 – Feb 2023
EDINET
2023-01-12
Quarterly Securities Report
Period: Sep 2022 – Nov 2022
EDINET
2022-10-14
Quarterly Securities Report
EDINET
2022-08-26
Annual Securities Report
EDINET
2022-04-13
Quarterly Securities Report
EDINET
2022-01-14
Quarterly Securities Report
EDINET
2021-10-15
Quarterly Securities Report
EDINET
2021-08-27
Annual Securities Report
EDINET
2021-04-14
Quarterly Securities Report
EDINET
2021-01-14
Quarterly Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →